Wave Life Sciences Ltd. (NASDAQ: WVE) Sees New Price Target and Public Offering

Raymond James sets a new price target of $21 for NASDAQ:WVE, suggesting a potential increase of 13.39% from the current price.Wave Life Sciences announces a public offering valued at $250 million, including ordinary shares and pre-funded warrants.The stock has experienced a remarkable increase of 147.26%, with today's price fluctuating between $12.72 and $19.54.Wave Life Sciences Ltd. (NASDAQ: WVE) is a clinical-stage biotechnology company focused on developing innovative therapies for genetic diseases. On ...